Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion type Assertion NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_head.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion description "[For brain metastases, FOXA1 expression was slightly higher in the SCC samples (55.6%) compared with the non-matched primary SCC tumor samples (43.4%), whereas NKX2-1 expression was comparable in both primary tumors and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion evidence source_evidence_literature NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion SIO_000772 22383183 NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion wasDerivedFrom befree-20140225 NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.
- NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_assertion wasGeneratedBy ECO_0000203 NP609253.RALWvrXK5D5IQwY3JrqVVo4EaElZ56Ubuz8l1WLE1b2mk130_provenance.